Filing Details
- Accession Number:
- 0001209191-10-042542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-13 13:00:00
- Reporting Period:
- 2010-08-13
- Filing Date:
- 2010-08-13
- Accepted Time:
- 2010-08-13 14:43:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388195 | Pharmerica Corp | PMC | Retail-Drug Stores And Proprietary Stores (5912) | 870792558 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1194422 | S Gregory Weishar | 1901 Campus Place Louisville KY 40299 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2010-08-13 | 1,000 | $7.65 | 1,000 | No | 4 | P | Indirect | By Son |
Common Stock, $.01 Par Value | Acquisiton | 2010-08-13 | 400 | $7.63 | 400 | No | 4 | P | Indirect | By Spouse |
Common Stock, $.01 Par Value | Acquisiton | 2010-08-13 | 1,800 | $7.64 | 2,200 | No | 4 | P | Indirect | By Spouse |
Common Stock, $.01 Par Value | Acquisiton | 2010-08-13 | 800 | $7.65 | 3,000 | No | 4 | P | Indirect | By Spouse |
Common Stock, $.01 Par Value | Acquisiton | 2010-08-13 | 77,000 | $7.68 | 396,294 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Son |
No | 4 | P | Indirect | By Spouse |
No | 4 | P | Indirect | By Spouse |
No | 4 | P | Indirect | By Spouse |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price ranging from $7.61 to $7.70, inclusive. The reporting person undertakes to provide to PharMerica Corporation, any security holder of PharMerica Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.